Killing of K562 cells with conjugates between human transferrin and a ribosome‐inactivating protein (SO‐6)
- 12 March 1988
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 68 (3) , 379-384
- https://doi.org/10.1111/j.1365-2141.1988.tb04218.x
Abstract
Summary Cellular iron uptake is mediated by binding of transferrin with specific surface receptors and internalization of the Fe‐transferrin‐receptor complex. This has been examined as a possible pathway for carrying into leukaemic cells a ribosome‐inactivating protein (RIP), SO‐6, derived from Saponaria officinalis. Purified human differic transferrin was conjugated with SO‐6 and a pool of proteins was obtained, with variable numbers of SO‐6 molecules linked to a single transferrin molecule. Human erythroleukaemic K562 cells were grown in the presence of human transferrin, SO‐6 and human transferrin conjugated with SO‐6. The conjugate was found to be internalized via binding with transferrin receptor. Whereas the presence of unconjugated human transferrin and SO‐6 in the medium did not significantly influence K562 cell growth, the conjugated proteins displayed an inhibitory activity on cell proliferation. This was maximal after 72 h at a transferrin concentration of 10‐9m, with about 50% of cells being killed. Bovine transferrin, present in fetal calf serum, did not appear to compete with human diferric transferrin in binding to K562 cells in suspension culture. In a clonogenic assay, colony formation by leukaemic cells was not influenced by free SO‐6 or transferrin, whereas the conjugated proteins were markedly inhibitory (about 100% at 10‐9m). Our findings indicate that SO‐6 can be efficiently carried into mammalian cells via the transferrin‐transferrin receptor cycle and exert its ribosome inactivating activity. This is in keeping with the existence of an alternative pathway of transferrin endocytosis in addition to the classic acidic endosome pathway. From a practical viewpoint, conjugates between transferrin and SO‐6 can be useful tools for studying the expression of transferrin receptors, and deserve also to be investigated for a possible use in cancer therapy.This publication has 24 references indexed in Scilit:
- Comparative studies of the binding and growth‐supportive ability of mammalian transferrins in human cellsJournal of Cellular Physiology, 1986
- Demonstration of the specific binding of bovine transferrin to the human transferrin receptor in k562 cells: Evidence for interspecies transferrin internalizationJournal of Cellular Physiology, 1986
- Exposure of K562 cells to anti-receptor monoclonal antibody OKT9 results in rapid redistribution and enhanced degradation of the transferrin receptor.The Journal of cell biology, 1986
- Characterization of a Saponaria officinalis seed ribosome-inactivating protein: Immunoreactivity and sequence homologiesBiochemical and Biophysical Research Communications, 1985
- Killing of human tumor cells in culture with adriamycin conjugates of human transferrinClinical Immunology and Immunopathology, 1984
- Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation. Effects of gallium and dimethylsulfoxide.Journal of Clinical Investigation, 1983
- Transferrin receptors and iron uptake during erythroid cell developmentBiochimica et Biophysica Acta (BBA) - Biomembranes, 1982
- Anti-transferrin receptor monoclonal antibody and toxin–antibody conjugates affect growth of human tumour cellsNature, 1981
- TRANSFERRIN AND TRANSFERRIN RECEPTORS IN CARCINOMA OF THE BREASTThe Lancet, 1980
- TRANSFER OF IRON FROM SERUM IRON-BINDING PROTEIN TO HUMAN RETICULOCYTES*Journal of Clinical Investigation, 1959